Obstet Gynecol Sci.  2024 Jan;67(1):76-85. 10.5468/ogs.23151.

Survival probabilities and prognostic factors of pregnancy-associated breast cancer in Malaysian women

• Abrar SS
• Norsa’adah B
• Yahya MM
• Isa JA
• Zon EM

• KMID: 2550488
• DOI: http://doi.org/10.5468/ogs.23151

Abstract

Objective
Pregnancy-associated breast cancer (PABC) is a rare cancer. This study aimed to determine the survival probabilities and prognostic factors in patients with PABC.
Methods
A retrospective cohort study was conducted in two tertiary care hospitals in Kota Bharu. We included all patients with breast cancer who were diagnosed by histopathology while pregnant or within 2 years post-partum from 2001 through 2020. We matched patients with PABC to non-pregnant patients with breast cancer by age and year of diagnosis. The data were analyzed using Cox proportional hazard regression.
Results
A total of 35 cases of PABC and 70 non-PABC controls were recruited. The 3-year, 5-year, and 10-year survival probabilities for patients with PABC were 58.6%, 47.54%, and 38.03%, respectively. The patients with PABC had a non-significant difference in survival probabilities compared with non-PABC patients. The significant prognostic factors of PABC were age (adjusted hazard ratio [aHR], 0.91; 95% confidence interval [CI], 0.86-0.96; P=0.001), advanced stage of cancer (aHR, 9.97; 95% CI, 3.96-25.2; P<0.001), and no surgery (aHR, 3.16; 95% CI, 1.01-9.85; P=0.047). Pregnancy was not found to be an independent factor in the prognosis of PABC (aHR, 0.72; 95% CI, 0.39-1.28; P=0.266).
Conclusion
Women diagnosed with PABC had similar survival probabilities compared with non-PABC patients. Pregnancy was not an independent prognostic factor for breast cancer. This information can be useful when women with breast cancer are counseled and supported with the option of beginning treatment with pregnancy continuation.

Keyword

Breast cancer; Pregnancy; Survival analysis; Prognostic factor

Figure

• 

  Fig 1 Survival functions of the PABC and non-PABC groups. PABC, pregnancy-associated breast cancer.

Reference

References

1. Lee MS, ‘Azmiyaty Amar Ma’ Ruf C, Nadhirah Izhar DP, Nafisah Ishak S, Wan Jamaluddin WS, Ya’acob SNM, et al. Awareness on breast cancer screening in Malaysia: a cross sectional study. Biomedicine (Taipei). 2019; 9:18.

2. Ministry of Health Malaysia. Malaysia national cancer registry report (2012–2016) [Internet]. Putrajaya: National Cancer Registry Department, National Cancer Institute;c2019. [cited 2022 Dec 15]. Available from: https://www.moh.gov.my/moh/resources/Penerbitan/Laporan/Umum/2012-2016%20(MNCRR)/Summary_MNCR_2012-2016_-_06112020.pdf .

3. Johansson ALV, Andersson TM, Hsieh CC, Jirström K, Cnattingius S, Fredriksson I, et al. Tumor characteristics and prognosis in women with pregnancy-associated breast cancer. Int J Cancer. 2018; 142:1343–54.

4. Johansson ALV, Stensheim H. Epidemiology of pregnancy-associated breast cancer. Adv Exp Med Biol. 2020; 1252:75–9.

5. Margioula-Siarkou G, Margioula-Siarkou C, Petousis S, Vavoulidis E, Margaritis K, Almperis A, et al. Breast carcinogenesis during pregnancy: molecular mechanisms, maternal and fetal adverse outcomes. Biology (Basel). 2023; 12:408.

6. Moreira WB, Brandão EC, Soares AN, Lucena CE, Antunes CM. Prognosis for patients diagnosed with pregnancy-associated breast cancer: a paired case-control study. Sao Paulo Med J. 2010; 128:119–24.

7. Dimitrakakis C, Zagouri F, Tsigginou A, Marinopoulos S, Sergentanis TN, Keramopoulos A, et al. Does pregnancy-associated breast cancer imply a worse prognosis? A matched case-case study. Breast Care (Basel). 2013; 8:203–7.

8. Shao C, Yu Z, Xiao J, Liu L, Hong F, Zhang Y, et al. Prognosis of pregnancy-associated breast cancer: a meta-analysis. BMC Cancer. 2020; 20:746.

9. Nagatsuma AK, Shimizu C, Takahashi F, Tsuda H, Saji S, Hojo T, et al. Impact of recent parity on histopathological tumor features and breast cancer outcome in premenopausal Japanese women. Breast Cancer Res Treat. 2013; 138:941–50.

10. Rodriguez AO, Chew H, Cress R, Xing G, McElvy S, Danielsen B, et al. Evidence of poorer survival in pregnancy-associated breast cancer. Obstet Gynecol. 2008; 112:71–8.

11. Halaska MJ, Pentheroudakis G, Strnad P, Stankusova H, Chod J, Robova H, et al. Presentation, management and outcome of 32 patients with pregnancy-associated breast cancer: a matched controlled study. Breast J. 2009; 15:461–7.

12. Azim HA Jr, Kroman N, Paesmans M, Gelber S, Rotmensz N, Ameye L, et al. Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study. J Clin Oncol. 2013; 31:73–9.

13. Amant F, von Minckwitz G, Han SN, Bontenbal M, Ring AE, Giermek J, et al. Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study. J Clin Oncol. 2013; 31:2532–9.

14. Ploquin A, Pistilli B, Tresch E, Frenel JS, Lerebours F, Lesur A, et al. 5-year overall survival after early breast cancer diagnosed during pregnancy: a retrospective case-control multicentre French study. Eur J Cancer. 2018; 95:30–7.

15. Stensheim H, Møller B, van Dijk T, Fosså SD. Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. J Clin Oncol. 2009; 27:45–51.

16. Baulies S, Cusidó M, Tresserra F, Fargas F, Rodríguez I, Úbeda B, et al. Biological and pathological features in pregnancy-associated breast cancer: a matched case-control study. Eur J Gynaecol Oncol. 2015; 36:420–3.

17. Norsa’adah B, Rampal KG, Rahmah MA, Naing NN, Biswal BM. Diagnosis delay of breast cancer and its associated factors in Malaysian women. BMC Cancer. 2011; 11:141.

18. Zhang R, Liu X, Huang W, Shao B, Yan Y, Liang X, et al. Clinicopathological features and prognosis of patients with pregnancy-associated breast cancer: a matched case control study. Asia Pac J Clin Oncol. 2021; 17:396–402.

19. Hosmer DW, Lemeshow S. Regression modelling of time to event data. 2nd ed. New York: Wiley;2019.

20. Genin AS, De Rycke Y, Stevens D, Donnadieu A, Langer A, Rouzier R, et al. Association with pregnancy increases the risk of local recurrence but does not impact overall survival in breast cancer: a case-control study of 87 cases. Breast. 2016; 30:222–27.

21. Gooch JC, Chun J, Kaplowitz E, Guth A, Axelrod D, Shapiro R, et al. Pregnancy-associated breast cancer in a contemporary cohort of newly diagnosed women. Breast J. 2020; 26:668–71.

22. Bae SY, Kim KS, Kim JS, Lee SB, Park BW, Lee SW, et al. Neoadjuvant chemotherapy and prognosis of pregnancy-associated breast cancer: a time-trends study of the Korean breast cancer registry database. J Breast Cancer. 2018; 21:425–32.

23. Framarino-Dei-Malatesta M, Piccioni MG, Brunelli R, Iannini I, Cascialli G, Sammartino P. Breast cancer during pregnancy: a retrospective study on obstetrical problems and survival. Eur J Obstet Gynecol Reprod Biol. 2014; 173:48–52.

24. Jin YC, Du JX, Fu SM, Chen Q, Qiu YR, Pei A, et al. A retrospective clinical study of patients with pregnancyassociated breast cancer among multiple centers in China (CSBrS-008). Chin Med J (Engl). 2021; 134:2186–95.

25. Liao Q, Deng D, Xie Q, Gong X, Meng X, Xia Y, et al. Clinical characteristics, pregnancy outcomes and ovarian function of pregnancy-associated breast cancer patients: a retrospective age-matched study. BMC Cancer. 2022; 22:152.

26. Murphy CG, Mallam D, Stein S, Patil S, Howard J, Sklarin N, et al. Current or recent pregnancy is associated with adverse pathologic features but not impaired survival in early breast cancer. Cancer. 2012; 118:3254–9.

27. Ali SA, Gupta S, Sehgal R, Vogel V. Survival outcomes in pregnancy associated breast cancer: a retrospective case control study. Breast J. 2012; 18:139–44.

28. Choi M, Han J, Yang BR, Jang MJ, Kim M, Kim TY, et al. Prognostic impact of pregnancy in Korean patients with breast cancer. Oncologist. 2019; 24:e1268–76.

29. Xiong Q, Valero V, Kau V, Kau SW, Taylor S, Smith TL, et al. Female patients with breast carcinoma age 30 years and younger have a poor prognosis: the M.D. Anderson Cancer Center experience. Cancer. 2001; 92:2523–8.

30. Ferguson NL, Bell J, Heidel R, Lee S, Vanmeter S, Duncan L, et al. Prognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and pathologic tumor characteristics on breast cancer survival in Caucasian women. Breast J. 2013; 19:22–30.

31. Lian W, Fu F, Lin Y, Lu M, Chen B, Yang P, et al. The impact of young age for prognosis by subtype in women with early breast cancer. Sci Rep. 2017; 7:11625.

32. Liu Z, Sahli Z, Wang Y, Wolff AC, Cope LM, Umbricht CB. Young age at diagnosis is associated with worse prognosis in the Luminal A breast cancer subtype: a retrospective institutional cohort study. Breast Cancer Res Treat. 2018; 172:689–702.

33. Zhong W, Tan L, Jiang WG, Chen K, You N, Sanders AJ, et al. Effect of younger age on survival outcomes in T1N0M0 breast cancer: a propensity score matching analysis. J Surg Oncol. 2019; 119:1039–46.

34. Walker RA, Lees E, Webb MB, Dearing SJ. Breast carcinomas occurring in young women (< 35 years) are different. Br J Cancer. 1996; 74:1796–800.

35. Sidoni A, Cavaliere A, Bellezza G, Scheibel M, Bucciarelli E. Breast cancer in young women: clinicopathological features and biological specificity. Breast. 2003; 12:247–50.

36. Verkooijen HM, Fioretta GM, Rapiti E, Bonnefoi H, Vlastos G, Kurtz J, et al. Patients’ refusal of surgery strongly impairs breast cancer survival. Ann Surg. 2005; 242:276–80.

37. Han BY, Li XG, Zhao HY, Hu X, Ling H. Clinical features and survival of pregnancy-associated breast cancer: a retrospective study of 203 cases in China. BMC Cancer. 2020; 20:244.